Eventide Asset Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-770,691	Closed	-$5.14M	–	250
2025 Q1	$5.14M	Hold	770,691	–	–	0.1%	144
2024 Q4	$9.69M	Hold	770,691	–	–	0.18%	132
2024 Q3	$14.2M	Hold	770,691	–	–	0.25%	104
2024 Q2	$16.6M	Buy	770,691 +279,959	+57%	+$6.43M	0.28%	102
2024 Q1	$13.2M	Hold	490,732	–	–	0.21%	109
2023 Q4	$14.7M	Sell	490,732 -407,268	-45%	-$8.99M	0.24%	105
2023 Q3	$18.4M	Hold	898,000	–	–	0.33%	90
2023 Q2	$17.8M	Hold	898,000	–	–	0.3%	90
2023 Q1	$15.4M	Buy	898,000 +427,346	+91%	+$8.37M	0.28%	98
2022 Q4	$9.21M	Buy	+470,654	New	+$8.67M	0.18%	112
2020 Q4	–	Sell	-1,550,000	Closed	-$35.4M	–	169
2020 Q3	$35.4M	Hold	1,550,000	–	–	0.71%	50
2020 Q2	$32.4M	Buy	1,550,000 +135,000	+10%	+$2.43M	0.73%	54
2020 Q1	$19.7M	Hold	1,415,000	–	–	0.66%	61
2019 Q4	$32.2M	Hold	1,415,000	–	–	0.91%	43
2019 Q3	$16.5M	Buy	1,415,000 +420,686	+42%	+$5.22M	0.54%	61
2019 Q2	$14.9M	Buy	994,314 +285,714	+40%	+$4.99M	0.45%	70
2019 Q1	$12.4M	Hold	708,600	–	–	0.43%	69
2018 Q4	$10.5M	Buy	708,600 +314,015	+80%	+$5.21M	0.46%	67
2018 Q3	$9.71M	Hold	394,585	–	–	0.36%	77
2018 Q2	$7.75M	Hold	394,585	–	–	0.32%	82
2018 Q1	$7.4M	Buy	+394,585	New	+$6.43M	0.35%	77

Other funds holding RCKT